Non-IBD immunological diseases are a risk factor for reduced survival in PSC. (Q38060237)

28 August 2017

title

Non-IBD immunological diseases are a risk factor for reduced survival in PSC. (English)

1 reference

28 August 2017

0 references

8

Daniel N Gotthardt

1 reference

28 August 2017

7

Wolfgang Stremmel

1 reference

28 August 2017

Christian Rupp

1

1 reference

28 August 2017

Anne Mummelthei

2

1 reference

28 August 2017

Peter Sauer

3

1 reference

28 August 2017

Karl H Weiss

4

1 reference

28 August 2017

Peter Schirmacher

5

1 reference

28 August 2017

Adolf Stiehl

6

1 reference

28 August 2017

publication date

14 November 2012

1 reference

28 August 2017

1 reference

28 August 2017

volume

33

1 reference

28 August 2017

issue

1

1 reference

28 August 2017

page(s)

86-93

1 reference

Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology

28 August 2017

cites work

1 reference

Natural history and prognostic models in primary sclerosing cholangitis

21 January 2018

1 reference

Immunopathogenesis of primary sclerosing cholangitis

21 January 2018

1 reference

The challenges in primary sclerosing cholangitis--aetiopathogenesis, autoimmunity, management and malignancy

21 January 2018

1 reference

Chronic thyroiditis and autoimmunization

21 January 2018

1 reference

Defining criteria for autoimmune diseases (Witebsky's postulates revisited)

21 January 2018

1 reference

A proposed classification of the immunological diseases

21 January 2018

1 reference

Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*)

21 January 2018

1 reference

Influence of microbial environment on autoimmunity.

21 January 2018

1 reference

Association of primary sclerosing cholangitis with HLA-B8.

21 January 2018

1 reference

Genome-wide association analysis in primary sclerosing cholangitis

21 January 2018

1 reference

Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci

21 January 2018

1 reference

High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6

21 January 2018

1 reference

Sjogren's syndrome in a patient with ulcerative colitis and primary sclerosing cholangitis: Case report and review of the literature

21 January 2018

1 reference

Immune-mediated diseases in primary sclerosing cholangitis

21 January 2018

1 reference

Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis

21 January 2018

1 reference

Endoscopic dilation of dominant stenoses in primary sclerosing cholangitis: outcome after long-term treatment

21 January 2018

1 reference

Primary sclerosing cholangitis--what is the difference between east and west?

21 January 2018

1 reference

The prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse population

21 January 2018

1 reference

Overlap syndromes of cholestatic liver diseases and auto-immune hepatitis.

21 January 2018

1 reference

Immunopathogenesis of inflammatory bowel disease: current concepts

21 January 2018

1 reference

Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis

21 January 2018

1 reference

In PSC with dominant bile duct stenosis, IBD is associated with an increase of carcinomas and reduced survival

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/LIV.12028

1 reference

28 August 2017

1 reference